Table 1 Demographic and clinicopathological characteristics of 76 patients with SPNP in our cohort
Characteristics | Parameters | ||
|---|---|---|---|
Age (Σ = 76) | Mean (y, ±SD) | 33.03 ± 17.05 | |
Median (y, range) | 30 (8–90) | ||
Gender (Σ = 76) | Male (%) | 17 (22.4%) | |
Female (%) | 59 (77.6%) | ||
Location (Σ = 76) | Head/Neck (%) | 40 (52.6%) | |
Body/Tail (%) | 36 (47.4%) | ||
Tumor size (Σ = 76) | Mean (cm, ±SD) | 5.9 ± 3.3 | |
Median (cm, range) | 5.0 (1.2–16.0) | ||
Symptom (Σ = 76) | Abdominal pain (%) | 29 (38.2%) | |
Asymptomatic (%) | 36 (47.4%) | ||
Mass (%) | 5 (6.6%) | ||
Other (%) | 6 (7.9%) | ||
Immunohistochem istry | Σ71 | Vim (Pos itive, %) | 71 (100 .0%) |
Σ69 | PR (Positive, %) | 68 (98.6%) | |
Σ70 | Syn (Positive, %) | 43 (61.4%) | |
Σ72 | CD10 (Positive, %) | 68 (94.4%) | |
Σ71 | Ki67 (Low proliferation activity, %) | 69 (97.2%) | |
Σ73 | β-catenin (Positive, %) | 73 (100.0%) | |
Σ71 | CgA (Negative, %) | 67 (94.4%) | |
Tumor marker | Σ72 | CEA (ng/ ml, ±SD) | 1.41 ± 0.83 |
Σ72 | CA199 (U/ml, ±SD) | 16.25 ± 31.33 | |
Σ45 | NSE (ug/L, ±SD) | 21.87 ± 14.64 | |
Operation Method (Σ = 75) | Pancreaticoduodenectomy (%) | 23 (30.7%) | |
Duodenum preserving pancreatic head resection (%) | 7 (9.3%) | ||
Enucleation (%) | 2 (2.7%) | ||
Central pancreatectomy (%) | 8 (10.7%) | ||
Distal pancreatectomy (%) | 5 (6.7%) | ||
Distal pancreatectomy with splenectomy (%) | 30 (40.0%) | ||
Follow-up (Σ = 66) | Mean (mo, ±SD) | 28.65 ± 19.22 | |
Median (mo, range) | 23.5 (4.0–68.0) | ||
Recurrence/metas tasis (Σ = 66) | 6 (9.1%) | ||
Disease related mortality (Σ = 66) | 5 (7.6%) |